Return to homepagePandemic Pact

Niclosamide intramuscular depot injection for dengue virus disease

Grant number: RF-TAA-2021-T02

Grant search

Key facts

  • Disease

    Dengue

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $312,650

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Daniel Jang

  • Research Location

    41

  • Lead Research Institution

    Daewoong Therapeutics

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of Niclosamide IM Depot Injection (DWRX2003) as a Treatment for Dengue Infection